Das könnte Sie auch interessieren:

Alternative Bank Schweiz blickt erneut auf ein erfolgreiches Jahr zurück

Olten (ots) - Die Alternative Bank Schweiz AG hat 2018 ein gutes Ergebnis erzielt. Sie weist einen Gewinn ...

Tanzcafé Arlberg Music Festival

Lech Zürs am Arlberg (ots) - Mit High Speed-Polka bis Swing ab in den Frühling beim Music Festival in Lech Zürs ...

Erfolgreiches Geschäftsjahr 2018 der EGK-Gesundheitskasse - 100 Jahre und gesund wie nie

Laufen (ots) - Sperrfrist bis 22.03.2019, 08:00 Uhr Der erfolgreiche Abschluss des Geschäftsjahres ...

11.12.2007 – 08:26

Dr. Hönle AG

euro adhoc: Dr. Hönle AG
Mergers - Acquisitions - Takeovers
Hönle Acquires Adhesives Specialist Panacol

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc. The issuer is responsible   for the content of this announcement. --------------------------------------------------------------------------------@@end@@


Dr. Hönle AG (ISIN: DE0005157101), Gräfelfing, Munich, a leading systems supplier of industrial UV technology, acquires all shares in Panacol AG, Switzerland. The Panacol Group is profitable and, with about 70 employees, generates annual revenues of approximately EUR 12 million.

The corporate group develops, produces and markets adhesives, and has three significant business locations in France, Germany and Switzerland. In addition, an international sales network exists through subsidiaries and cooperations. Panacol´s brand products are well-established on the industrial adhesives growth market, and the company supplies a broad customer base with its products.

The Hönle Group aims at further extending its systems competence through this acquisition and at increasing the proportion of the continuous share of consumer goods in group revenue. Moreover, it will benefit from development and sales synergy effects within the Hönle Group. The existing adhesives business, which has been carried out through Wellomer GmbH to date, will be substantially extended as a result of the Panacol Group acquisition.

The purchase agreement stipulates acquisition of Panacol AG as of 1 January 2008. With the takeover of the Panacol Group, annualised consolidated revenue of the Hönle Group will rise to nearly EUR 40 million.

@@start.t2@@end of announcement                                                 euro adhoc 11.12.2007 07:50:21

ots Originaltext: Dr. Hönle AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Peter Weinert
Tel.: +49 (0)89 856 08 173
E-Mail: peter.weinert@hoenle.de

Branche: Instrument Engineering
ISIN:      DE0005157101
WKN:        515710
Index:    CDAX, Prime All Share, Technologie All Share
Börsen:  Börse Frankfurt / regulated dealing/prime standard
              Börse Berlin / free trade
              Börse Hamburg / free trade
              Börse Stuttgart / free trade
              Börse Düsseldorf / free trade
              Börse Hannover / free trade
              Börse München / free trade

Alle Meldungen
Abonnieren Sie alle Meldungen von Dr. Hönle AG
  • Druckversion
  • PDF-Version

Themen in dieser Meldung

Weitere Meldungen: Dr. Hönle AG